A randomized, double-blind, placebo-controlled study of rapid-acting intramuscular olanzapine in Japanese patients for schizophrenia with acute agitation

A randomized, double-blind, placebo-controlled study of rapid-acting intramuscular olanzapine in Japanese patients for schizophrenia with acute agitation

<p>Abstract</p> <p>Background</p> <p>Olanzapine rapid-acting intramuscular (IM) injection is an atypical antipsychotic drug already used overseas and recently approved in Japan. The objective of this study was to confirm the efficacy of rapid-acting IM olanzapine 10 mg...

Full description

Bibliographic Details
Main Authors: Katagiri Hideaki, Fujikoshi Shinji, Suzuki Takuya, Fujita Kiyoshi, Sugiyama Naoya, Takahashi Michihiro, Gomez Juan-Carlos
Format: Article
Language:English
Published: BMC 2013-01-01
Series:BMC Psychiatry
Subjects:
Rapid-acting intramuscular olanzapine
Schizophrenia
Acute psychotic agitation
Japanese
Online Access:http://www.biomedcentral.com/1471-244X/13/20

Similar Items

Similar Items